Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

22

Revenue 2017

Baxter

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Baxter's 2013 sales performance.

Baxter International Inc.

FDA deals a big blow to Shire's late-stage pipeline

FDA deals a big blow to Shire's late-stage pipeline impact on Shire's ongoing $30bn pursuit of Baxter spin-out Baxalta.

Astellas selects new CFO for its EMEA operations

Astellas selects new CFO for its EMEA operations McGarvey most recently served as communications lead for global process and systems implementation programs at Baxter International and has also worked in various internal and external communications roles in Chicago at

Pharma deals in August 2015

Pharma deals in August 2015 Baxalta was of course only spun out from its parent company Baxter in July so this bid is fairly fast and the offer was, not surprisingly, met with a lukewarm response.

Baxalta spells out opposition to Shire

Baxalta spells out opposition to Shire from Baxter - still has to find its natural level. ... One of the advantages the separation from Baxter created is a lean and focused infrastructure here at Baxalta, but an acquirer like Shire isn't just going to find easy savings

Shire makes shock $30bn bid for Baxalta

Shire makes shock $30bn bid for Baxalta Irish firm seeking to buy the newly spun-out biotech that used to be part of Baxter. ... After nearly being acquired by AbbVie last year Shire its now making its own major takeover move on Baxalta - but the Baxter spin-out is not making any deal easy.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...